Physician profile
Andrew Todd
NPI 1104021526
$12,489.28
in general payments reported to CMS, 2019-2025
12 companies · $90.54 in 2025
The $90.54 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.69 · 2020: $12K · 2022: $286 · 2023: $81.36 · 2024: $233 · 2025: $90.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $11,750.04 | 2020-2022 | |
| Highridge Medical LLC | $150.00 | 2024 | The Tether |
| Depuy Synthes Sales INC. | $147.38 | 2022-2024 | Fibergraft Bg Morsels |
| Nevro Corp. | $98.69 | 2019 | |
| Sumitomo Pharma America, INC. | $88.73 | 2023-2025 | Gemtesa |
| Stryker Corporation | $75.29 | 2022 | |
| Vericel Corporation | $44.39 | 2024 | Maci |
| Acera Surgical, INC. | $33.53 | 2025 | Restrata Wound Matrix |
| Providence Medical Technology, INC. | $30.50 | 2022 | |
| Medtronic, INC. | $26.37 | 2025 | Osteocool Rf Ablation System |
| Bioventus LLC | $23.27 | 2023 | |
| Innovation Technologies INC | $21.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.